Apptly Health Technologies Corp. (ESVNF) Stock Price & Analysis
Apptly Health Technologies Corp. (ESVNF) — price $0.1293 (+57.66%), as of the Oct 5, 2026 trading session.
Educational signal · not a buy or sell recommendation · How to read this
Apptly Health Technologies Corp. · ESVNF
Serra Energy Metals Corp. is a Canadian company focused on acquiring, exploring, and developing green metal projects. The company targets drill-ready exploration sites near existing infrastructure.
Price as of Oct 5, 2026
Key Statistics
MoonshotScore is not published for this security.
Price & valuation
| Measure | Value | As of |
|---|---|---|
| Latest provided price | $0.1293 | |
| Change on the day | +57.66% | |
| 52-week range | $0.031 – $0.3805 | |
| Price / earnings (trailing) | 4.08 | |
| Shares traded on the day | 5.0K |
Price & events
Other perspectives
Council score for Apptly Health Technologies (ESVNF): perspectives
Council is a separate blend of available disciplines; MoonshotScore above remains the five-pillar research rating.
9-Factor Breakdown
Legends Council
3 lenses, 0 current
AI simulations built from the named investors' published principles. Not affiliated with, endorsed by, or the opinion of these individuals. How these lenses are built
Read on: Sep 10, 2026 · older than the 27 hours refresh window; not a current reading
Munger's Mindset
Balance Sheet & Valuation · historical
Read on: Sep 10, 2026 · older than the 27 hours refresh window; not a current reading
How to read these bars and different assessments
Council is a separate blend of available disciplines; MoonshotScore above remains the five-pillar research rating.
Bars show each model's ordered assessment on its own scale, not a probability or a comparable investment return. The adjacent words give the assessment; more filled segments indicate a stronger model reading.
On Sep 10, 2026, the Munger lens read the price at that time as fairly valued against its own estimate of value.
Readings on this page are from Oct 6, 2026, except a card that shows its own read date.
Watch the ESVNF film — every key number, told as a short cinematic story
~2 min · open the film
What is Apptly Health Technologies (ESVNF), and what does it report?
Short answer · as of
A current FMP business description is unavailable; the listing and provider classification below are the available identity facts. Apptly Health Technologies Corp. (ESVNF) is the company analyzed here. It is led by Sean Kearney. In Q4 FY2025 it reported revenue of $85,428.467 and net income of -$5M.
What do the latest results show for Apptly Health Technologies (ESVNF)?
Short answer · as of
The most recent reported quarter, Q4 FY2025, carried revenue of $85,428.467.
Quarterly income statement — 4 quarters
| Period | Revenue | Net income | EPS |
|---|---|---|---|
| Q4 FY2025 | $85,428.467 | -$5M | -$0.09 (diluted) |
| Q3 FY2025 | $0 | $202,994.793 | $0.03 (diluted) |
| Q2 FY2025 | $0 | $191,160.623 | $0.03 (diluted) |
| Q1 FY2025 | $0 | -$183,861.539 | -$0.03 (diluted) |
What are the financial strengths and risks for Apptly Health Technologies (ESVNF)?
Short answer
The distress and quality screens read Piotroski F 3. Trailing ratios: ROE 6.1% · ROA 4.3% · current ratio 21.15 · earnings yield 24.5%.
What has been published about Apptly Health Technologies (ESVNF)?
- Apptly Health Technologies to Present at the Life Sciences Investor Forum on September 17th
- Apptly Commences Trading on the OTCQB and Becomes DTC Eligible
- Apptly and Koning Announce Strategic Partnership to Expand Patient Access to Non-Compression 3D Breast Imaging
- Apptly Announces $1,000,000 Non-Brokered Private Placement
Investor Questions: ESVNF Stock
These answers are editorial: 1 of these 8 answers is drawn from the ESVNF research dossier (written Mar 17, 2026 by gemini-2.0-flash); the other 7 are question templates that restate figures shown above. Figures in this section are not part of the source register.
Is ESVNF a good stock to buy?
Stock Expert AI does not rate ESVNF buy, sell or hold. Apptly Health Technologies Corp. has no MoonshotScore yet; read the financial checkup, analyst consensus and risks directly. Whether it fits is your call: check what it sells, whether it earns and what the price assumes. This is educational content, not investment advice.
What is the ESVNF stock price today?
The last price recorded on this page for Apptly Health Technologies Corp. (ESVNF) is $0.1293, as of the Oct 5, 2026 trading session (source: Financial Modeling Prep (FMP) · quote). It is a provider snapshot, not a live exchange feed, so check a brokerage quote before you trade.
What does Serra Energy Metals Corp. do?
Serra Energy Metals Corp. is a Canadian-based company focused on the acquisition, exploration, and development of green metal projects. The company targets metals crucial for the green energy transition, such as lithium, nickel, and cobalt.
What are the key factors to evaluate for ESVNF?
Evaluate ESVNF on fundamentals, analyst consensus, and risk factors. P/E: 4.08x. Serra Energy Metals Corp. focuses on green metal projects, aligning with the growing demand for materials used in clean energy technologies. Not financial advice.
How frequently does ESVNF data refresh on this page?
ESVNF's price is the last quote we recorded, from the Oct 5, 2026 trading session. Pages are served from a cache, so the copy you are reading can lag that quote. The quote is a provider snapshot, not an exchange feed. Fundamentals follow quarterly filings. V2 is recalculated from the most recent completed US trading session; the score's own date shows its last successful run.
What has driven ESVNF's recent stock price performance?
Apptly Health Technologies Corp. (ESVNF) moves on earnings results, analyst revisions, sector rotation, and market sentiment. Notable catalyst: Focus on green metal projects aligns with growing demand. See the News tab for the latest drivers. Past performance does not predict future results.
Should investors consider ESVNF overvalued or undervalued right now?
Apptly Health Technologies Corp. (ESVNF) trades at 4.08x earnings. Compare P/E, P/S, and EV/EBITDA against sector peers for a full view.
How do I research ESVNF before investing?
Before investing in Apptly Health Technologies Corp. (ESVNF), research these four areas: (1) the company's revenue model and competitive position (see Company Overview), (2) financial health through revenue growth, margins, and cash flow (see MoonshotScore), (3) analyst consensus ratings and price targets (see Analyst tab), and (4) specific risk factors that could impact the stock (see Risk Factors section).
Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.
Machine-generated analysis by Stock Expert AI — model gemini-2.0-flash, generated Mar 17, 2026. Editorial oversight is systemic, not page-by-page. Editorially accountable: Sedat ANAK, Founder and Editor-in-Chief.
Sources — records for every figure on this page (12 figures)
The 12 rows below are exactly the facts the evidence-backed sections of this page printed — the 10-second verdict, the MoonshotScore, price and market value, the five questions with their receipts, and the records behind this page. Known dates and sources are recorded on their own rows; an em dash or UNRECORDED tier preserves a stored observation without inventing either. The quarterly income statement is provider-standardized (FMP) under one row, and scale definitions — a 0-100 rating, the band ladder, the Piotroski 0–9 range — are fixed rather than measured. No number in those sections was generated by a model. The register does not cover quoted third-party headlines, the dated council readings, or the Frequently Asked Questions; each of those says where it came from where it stands.
"As of" is the date the value is true for where the source carries one — a quarter end, a filing date, a price close, the day the score was computed. A cached observation with no source date remains undated; the page publication date is not used as a substitute.
FMP — 8 facts from Financial Modeling Prep endpoint families
| Fact ID | Fact | Value as shown | As of | Tier | Source |
|---|---|---|---|---|---|
px.last | Latest provided price | $0.1293 | FMP | Financial Modeling Prep (FMP) · quote — Dated to the US trading session the price belongs to, derived from the quote record's timestamp (weekend and pre-open reads roll back to the previous weekday; exchange holidays are not modelled). The record does not establish an exchange execution time. Retrieved 2026-10-05T13:44:53.484Z. | |
px.change | Change on the day | +57.66% | FMP | Financial Modeling Prep (FMP) · quote | |
px.change_abs | Change on the day, in dollars | +$0.04728 | FMP | Financial Modeling Prep (FMP) · quote | |
px.pe | Price / earnings (trailing) | 4.08 | FMP | Financial Modeling Prep (FMP) · quote | |
px.volume | Shares traded on the day | 5.0K | FMP | Financial Modeling Prep (FMP) · quote | |
fin.q_revenue | Revenue, Q4 FY2025 | $85,428.467 | FMP | Financial Modeling Prep (FMP) · income statement (quarterly) | |
fin.q_income | Net income, Q4 FY2025 | -$5M | FMP | Financial Modeling Prep (FMP) · income statement (quarterly) | |
fin.q_table | Quarterly income statement | 4 quarters through Q4 FY2025 | FMP | Financial Modeling Prep (FMP) · income statement (quarterly), as filed |
UNRECORDED — 4 facts from stored observations whose source was not recorded
| Fact ID | Fact | Value as shown | As of | Tier | Source |
|---|---|---|---|---|---|
px.range52 | 52-week range | $0.031 – $0.3805 | UNRECORDED | Stored company-profile observation — Captured 2026-10-04 | |
id.ceo | Chief executive | Sean Kearney | UNRECORDED | Stored company-profile observation — Captured 2026-10-04 | |
fin.scores | Distress and quality screens | Piotroski F 3 | UNRECORDED | Stored financial-scores observation — Captured 2026-10-05 | |
fin.ratios | Return and yield ratios (trailing twelve months) | ROE 6.1% · ROA 4.3% · current ratio 21.15 · earnings yield 24.5% | — | UNRECORDED | Stored key metrics — Date unknown |
- Published
- Research standards
- Methodology · Editorial policy · Corrections
- Report a number
- sedat@stockexpertai.com
Data provided for informational purposes only.